Cargando…
Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785022/ https://www.ncbi.nlm.nih.gov/pubmed/29370292 http://dx.doi.org/10.1371/journal.pone.0192059 |
| _version_ | 1783295558745587712 |
|---|---|
| author | Merchant, Mark Moffat, John Schaefer, Gabriele Chan, Jocelyn Wang, Xi Orr, Christine Cheng, Jason Hunsaker, Thomas Shao, Lily Wang, Stephanie J. Wagle, Marie-Claire Lin, Eva Haverty, Peter M. Shahidi-Latham, Sheerin Ngu, Hai Solon, Margaret Eastham-Anderson, Jeffrey Koeppen, Hartmut Huang, Shih-Min A. Schwarz, Jacob Belvin, Marcia Kirouac, Daniel Junttila, Melissa R. |
| author_facet | Merchant, Mark Moffat, John Schaefer, Gabriele Chan, Jocelyn Wang, Xi Orr, Christine Cheng, Jason Hunsaker, Thomas Shao, Lily Wang, Stephanie J. Wagle, Marie-Claire Lin, Eva Haverty, Peter M. Shahidi-Latham, Sheerin Ngu, Hai Solon, Margaret Eastham-Anderson, Jeffrey Koeppen, Hartmut Huang, Shih-Min A. Schwarz, Jacob Belvin, Marcia Kirouac, Daniel Junttila, Melissa R. |
| author_sort | Merchant, Mark |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5785022 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57850222018-02-09 Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors Merchant, Mark Moffat, John Schaefer, Gabriele Chan, Jocelyn Wang, Xi Orr, Christine Cheng, Jason Hunsaker, Thomas Shao, Lily Wang, Stephanie J. Wagle, Marie-Claire Lin, Eva Haverty, Peter M. Shahidi-Latham, Sheerin Ngu, Hai Solon, Margaret Eastham-Anderson, Jeffrey Koeppen, Hartmut Huang, Shih-Min A. Schwarz, Jacob Belvin, Marcia Kirouac, Daniel Junttila, Melissa R. PLoS One Correction Public Library of Science 2018-01-25 /pmc/articles/PMC5785022/ /pubmed/29370292 http://dx.doi.org/10.1371/journal.pone.0192059 Text en © 2018 Merchant et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Merchant, Mark Moffat, John Schaefer, Gabriele Chan, Jocelyn Wang, Xi Orr, Christine Cheng, Jason Hunsaker, Thomas Shao, Lily Wang, Stephanie J. Wagle, Marie-Claire Lin, Eva Haverty, Peter M. Shahidi-Latham, Sheerin Ngu, Hai Solon, Margaret Eastham-Anderson, Jeffrey Koeppen, Hartmut Huang, Shih-Min A. Schwarz, Jacob Belvin, Marcia Kirouac, Daniel Junttila, Melissa R. Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors |
| title | Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors |
| title_full | Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors |
| title_fullStr | Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors |
| title_full_unstemmed | Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors |
| title_short | Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors |
| title_sort | correction: combined mek and erk inhibition overcomes therapy-mediated pathway reactivation in ras mutant tumors |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785022/ https://www.ncbi.nlm.nih.gov/pubmed/29370292 http://dx.doi.org/10.1371/journal.pone.0192059 |
| work_keys_str_mv | AT merchantmark correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT moffatjohn correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT schaefergabriele correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT chanjocelyn correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT wangxi correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT orrchristine correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT chengjason correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT hunsakerthomas correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT shaolily correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT wangstephaniej correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT waglemarieclaire correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT lineva correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT havertypeterm correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT shahidilathamsheerin correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT nguhai correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT solonmargaret correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT easthamandersonjeffrey correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT koeppenhartmut correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT huangshihmina correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT schwarzjacob correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT belvinmarcia correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT kirouacdaniel correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors AT junttilamelissar correctioncombinedmekanderkinhibitionovercomestherapymediatedpathwayreactivationinrasmutanttumors |